- News & Views
- FDA approves first...
- FDA approves first over-the-counter blood glucose monitor for diabetes
News BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q611 (Published 11 March 2024) Cite this as: BMJ 2024;384:q611
- Janice Hopkins Tanne
- New York
The US Food and Drug Administration (FDA) has approved the first over-the-counter continuous blood glucose monitor.1
The Stelo Glucose Biosensor System is manufactured by Dexcom and will be available in the US this summer. It is intended for people over the age of 18 who do not use insulin, such as people who are treating their diabetes with oral …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£33 / $40 / €36 (excludes VAT)
You can download a PDF version for your personal record.
See Also
Zegalogue® Is Now Commercially Available In The United States - Beyond Type 1Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose SensorFreeStyle Libre 2 Sensor Kit - Box of 1FDA Clears First OTC Continuous Glucose MonitorBack to top
